Genmab



Ebitda Lave om Dato
Agios Pharmaceuticals USD -123670000 22.2M 2024-12
Almirall EUR 84.69M 66.19M 2024-06
Amarin USD -24415000 24.65M 2024-09
Amgen USD 3.71B 265M 2024-12
argenx SE 88.7M 103.13M 2024-09
AstraZeneca USD 5.26B 597M 2024-12
Bayer EUR 1.67B 3.36B 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Demant DKK 1.96B 1.65B 2020-12
Exelixis USD 171.1M 24.2M 2025-01
Fresenius Medical Care EUR 554.32M 256.68M 2024-12
Galapagos EUR -48446000 52.4M 2024-09
Genmab DKK 2.23B 85M 2024-09
GlaxoSmithKline GBP 2.08B 1.22B 2024-12
GN Store Nord DKK 923M 149M 2024-12
GRIFOLS EUR 536.1M 85.37M 2024-12
Hikma Pharmaceutical USD 453M 98M 2024-06
Insmed USD -241795000 46.45M 2024-12
Lonza CHF 873M 107M 2024-06
Merck EUR 1.62B 114M 2024-09
Novartis USD 5.19B 319M 2024-12
Regeneron Pharmaceuticals USD 1.06B 572.8M 2024-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.25B 2.22B 2024-09
UCB EUR 652M 105M 2024-06



Genmab - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.